Scilex

SCLXNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$43.824 M

$5.16 +2.38%

Close of 21 Sept 2026

Revenue

$30.3M

#2881 by revenue

Earnings

-$374.1M

Loss-making

Shares outstanding

8,493,000

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Scilex lists more than one class of stock. Company figures above cover all classes combined.

SCLXW

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#129TevogenTVGN$48.4M
#130Instil BioTIL$47.9M
#131ScilexSCLX$43.8M
#132Metagenomi TherapeuticsMGX$42.3M
#133ElutiaELUT$37.8M

What if Scilex were worth as much as…

Open the what-if tool →

Gold $30.3T

$3,564,589

Per share 690,812× higher

Bitcoin $1.72T

$202,496.61

Per share 39,244× higher

Nvidia $5.48T

$645,220.53

Per share 125,043× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Scilex are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.